NNNN
Anbio Biotechnology
6.20$
+1.1%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 42.6% | 46.6% | 49.9% | 28.1% | 12.8% | |
| 57.4% | 53.4% | 50.1% | 71.9% | 87.2% | |
| 0.0% | 0.8% | 2.0% | 5.5% | 2.3% | |
| 1.9% | 9.2% | 18.9% | 42.0% | 18.2% | |
| 1.9% | 10.1% | 20.9% | 47.5% | 20.5% | |
| 55.5% | 43.3% | 29.2% | 24.4% | 66.7% | |
| 0.0% | 0.0% | 0.0% | 0.0% | – | |
| 57.3% | 42.5% | 33.6% | 29.0% | 74.1% | |
| 57.3% | 42.5% | 33.6% | 29.0% | 74.1% | |
| 57.3% | 42.6% | 33.8% | 24.4% | 66.7% |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.